Evidence map›Paper›PMID 33923532›Full record

Trial reportNutrients2021

Treatment with a Probiotic Mixture Containing

Caterina Anania, Vincenza Patrizia Di Marino, Francesca Olivero, Daniela De Canditiis, Giulia Brindisi, Federico Iannilli, Giovanna De Castro, Anna Maria Zicari, Marzia Duse

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06372184 (Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis), which is not on this map. Cited by 31 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 5 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06372184 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Study

TypeinterventionalSponsorThe Second Hospital of Nanjing Medical UniversityRan2024 to 2029Enrolled32ConditionsRhinitis, AllergicArmsWashed Microbiota Transplantation, Placebo
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 5 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Efficacy ofJournal of Korean medical science · 2024
    Trial
  7. Trial
  8. Review
  9. Health benefits ofFrontiers in microbiology · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Survival and safety evaluation ofMicrobiology spectrum · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Alterations of gut microbiome in eosinophilic chronic rhinosinusitis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  19. RETRACTED: Effect ofMicroorganisms · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Caterina AnaniaImmunology and Allergology Unit, Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.
Vincenza Patrizia Di MarinoImmunology and Allergology Unit, Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.
Francesca OliveroPediatric Clinic, Department of Pediatrics, Fondazione IRCSS Policlinico San Matteo, University of Pavia, 27100 Pavia, Italy.
Daniela De CanditiisInstitute of Applied Calculus-CNR Rome, 00185 Rome, Italy.
Giulia BrindisiImmunology and Allergology Unit, Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-5059-6082
Federico IannilliImmunology and Allergology Unit, Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.
Giovanna De CastroImmunology and Allergology Unit, Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.
Anna Maria ZicariImmunology and Allergology Unit, Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.
Marzia DuseImmunology and Allergology Unit, Department of Mother-Child, Urological Science, Sapienza University of Rome, 00161 Rome, Italy.
Sapienza University of Rome · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProbiotics may prevent the allergic response development due to their anti-inflammatory and immunomodulatory effects. The aim of this study is to determine if the prophylactic treatment with a mixture of

methodsThe study included 250 children aged from 6 to 17 years, affected by AR. Patients were randomly assigned to the intervention group (150) or to the placebo group (100). Patients in the intervention group, in addition to conventional therapy (local corticosteroids and/or oral antihistamines), were treated in the 3 months preceding the onset of symptoms related to the presence of the allergen to which the children were most sensitized, with a daily oral administration of a probiotic mixture containing the

resultsthe patients in the intervention group had a significant reduction in their NSS after probiotic treatment (

conclusionsWhen administered as a prophylactic treatment, a mixture of BB12 and L3 statistically decreased signs and symptoms of AR and reduced significantly the need of conventional therapy.

Indexed as

Bifidobacterium animalisEnterococcus faeciumAdolescentChildDouble-Blind MethodFemaleHumansMaleProbioticsProspective StudiesRhinitis, AllergicTreatment Outcomeallergic rhinitisBifidobacterium animalis subsp. Lactis BB12childrenEnterococcus faecium L3probiotics

Identifiers

PMID33923532
PMCPMC8073063
OpenAlexW3137486720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.